Note: Ingredients listed on restricted chemical lists
EC/CAS
231-493-2/7585-39-9
Name of the chemical
β-dextrin
Concentration
N/A
General Information
Revision date
2020-07-04
Product name
Ziprasidone mesylate for injection
1.2.1 Relevant identified uses
Finished pharmaceutical product
Manufacturer Name
Gland pharma Limited
Icons in SDS
Company Information
company name
Gland pharma Limited
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
2.1 Classification of the substance or mixture
Skin Sensitization: Category 1 US OSHA Specific – Classification
Physical hazards
Combustible Dust
EU Classification
EU Indication of danger: Irritant EU Risk Phrases: R43 - May cause sensitization by skin contact
Signal word
Warning
Hazard statements
H317 - May cause an allergic skin reaction May form combustible dust concentrations in air
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P272 - Contaminated work clothing should not be allowed out of the workplace P280 - Wear protective gloves/protective clothing/eye protection/face protection P302+ P352 - IF ON SKIN: Wash with plenty of soap and water P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention P321 - Specific treatment (see supplemental first aid instructions on this label) P363 - Wash contaminated clothing before reuse
2.3 Other hazards
No data available Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace. SECTION 3 – COMPOSITION AND INGRIDIENTS Hazardous EU GHS Ingredient CAS Number EINECS/ELINCS EU % List Classification Sulfobutylether b-cyclodextrin sodium Skin Sens. 1 7585-39-9 231-493-2 Xi;43 * (SBECD) (H317) STOT RE.2 Ziprasidone mesylate trihydrate 185021-64-1 Not Listed Xn;R48/22 8.5 (H373) Additional Information: * Proprietary Ingredient(s) indicated as hazardous have been assessed under standards for workplace safety. In accordance with 29 CFR 1910.1200, the exact percentage composition of this mixture has been withheld as a trade secret. For the full text of the R phrases and CLP/GHS abbreviations mentioned in this Section, see Section 16
